Philips to Acquire Unisensor to Provide Near-Patient Testing and Monitoring Service
FREMONT, CA: Royal Philips, a diversified technology company, announced that it has signed an agreement to acquire Unisensor, an innovator in the field of optical analysis of fluids for diagnostic applications in health care, as well as other industries. The acquisition of Unisensor will empower Philips’ innovation capabilities in the field of patient sample analysis such as blood testing for applications in oncology therapy monitoring.
These innovations will help in improving patient care at a lower cost through enhanced patient triage and treatment at the point-of-care (near the patient). "Philips’ Healthcare Incubator has already produced promising early-stage businesses in the area of near-patient testing and monitoring for the hospital and the home,” said Perry van Rijsingen, General Manager for Philips Healthcare Incubator. “The acquisition of Unisensor will expand our technology platforms for miniaturized, mobile diagnostic solutions and support our ambition to become a leader in this new growth market for Philips.”
An analytical instrument from Unisensor called oCelloScope has found its use in cancer cell studies on a research application basis. The company is also making significant contribution in animal health and water analysis which Philips is willing to pursue further.